 - Previous or concurrent cancer that is distinct in primary site or histology from HCC except cervical carcinoma in situ, treated basal-cell carcinoma of the skin, superficial bladder tumors Ta, Tis T1, and any cancer curatively treated 3 years prior to entry is permitted 